California Medical Cannabis Evaluation - 91710 Chino, CA

Business Name: California Medical Cannabis Evaluation
Categorized In: Health Services
Address: 3757 Riverside Drive, Chino, CA 91710
Phone Number: (909) 548-7747
Contact Person: Fermin M Palos
NAICS Code: 621999
SIC Code: 8099
Business Type: B2C (Business to Consumer)
Founding Year: 2009
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $50.000 to $99.999
Share This Business:
Similar Businesses: Preferred Healthcare Inc - Chino, CA 91710
L&L Home Healthcare Services Inc - Chino, CA 91710
Serenity Medical Evalutions - Chino, CA 91710
Auto Clinic - Chino, CA 91710
Radha Menon Mda Medical Corp - Chino, CA 91710
Natura-Genics Inc - Chino, CA 91710
Montclair Ultrasound Health - Chino, CA 91710
Angelicare Home Health - Chino, CA 91710
Total Care Walk in Clinic - Chino, CA 91710
Brightstar Care - Chino, CA 91710
Zihua Car Clinic Inc - Chino, CA 91710
The Auto Clinic - Chino, CA 91710
Senior Helpers - Chino, CA 91710
Health Care Recovery Syst - Chino, CA 91710
Healthcare Resource Networ - Chino, CA 91710
Masep-Infini Medical Science Technology Development Co Ltd - Chino, CA 91710
Chino City Monte Vista Park - Chino, CA 91710
Total Wellness Inc - Chino, CA 91710
Bio Chem Medical - Chino, CA 91710
Family Specialty Care Medical - Chino, CA 91710

California Medical Cannabis Evaluation provides professional Health Services from its single location at the coordinates .

The company offers B2C variables under the SIC code 8099 and NAICS code 621999, while making an annual revenue of $50.000 to $99.999 and hiring a total of 1 to 4 employees.

Founded in 2009, the company can now be visited at 3757 Riverside Drive, Chino, California 91710 or contacted through representative Fermin M Palos at (909) 548-7747.

For frequently asked questions and further inquiries about professional Health Services, get to know more about California Medical Cannabis Evaluation through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.